Surveillance for Viral Hepatitis – United States, 2014

Entire report in a printable format (revised Sep 2016) pdf icon[PDF – 2MB – 65 pages]

Contents

  Summary*

  Hepatitis A

  Hepatitis B

  Hepatitis C

Discussion

Hepatitis A virus

Index
PAGE
DESCRIPTION
Table 2.1 Reported cases of hepatitis A, nationally and by state or jurisdiction ― United States, 2010-2014
Table 2.2 Clinical characteristics of reported cases of hepatitis A ― United States, 2014
Table 2.3 Number and rate of hepatitis A-related deaths, by demographic characteristics and year — United States, 2010–2014
Figure 2.1 Reported number of acute hepatitis A cases — United States, 2000-2014
Figure 2.2 Incidence of hepatitis A, by age group — United States, 2000-2014
Figure 2.3 Incidence of hepatitis A, by sex — United States, 2000-2014
Figure 2.4 Incidence of hepatitis A, by race/ethnicity — United States, 2000-2014
Figure 2.5 Availability of information on risk exposures/behaviors associated with hepatitis A – United States, 2014
Figure 2.6a Hepatitis A reports, by risk behavior — United States, 2014
Figure 2.6b Hepatitis A reports, by risk exposure — United States, 2014

Hepatitis A virus

Table 2.1 Reported cases of hepatitis A, nationally and by state or jurisdiction ― United States, 2010–2014

State
2010
2011
2012
2013
2014
No. Rate* No. Rate* No. Rate* No. Rate* No. Rate*
Alabama
8
0.2
8
0.2
19
0.4
10
0.2
15
0.3
Alaska
5
0.7
4
0.6
1
0.1
1
0.1
1
0.1
Arizona
61
1.0
77
1.2
93
1.4
66
1.0
29
0.4
Arkansas
2
0.1
3
0.1
8
0.3
9
0.3
2
0.1
California
242
0.6
186
0.5
209
0.5
255
0.7
142
0.4
Colorado
36
0.7
21
0.4
28
0.5
51
1.0
23
0.4
Connecticut
29
0.8
18
0.5
23
0.6
19
0.5
23
0.6
Delaware
7
0.8
2
0.2
9
1.0
4
0.4
1
0.1
District of Columbia
1
0.2
U
U
U
U
U
U
U
U
Florida
139
0.7
87
0.5
87
0.5
115
0.6
90
0.5
Georgia
40
0.4
27
0.3
46
0.5
36
0.4
24
0.2
Hawaii
8
0.6
8
0.6
5
0.4
16
1.1
5
0.4
Idaho
8
0.5
6
0.4
11
0.7
8
0.5
7
0.4
Illinois
48
0.4
73
0.6
67
0.5
79
0.6
82
0.6
Indiana
12
0.2
24
0.4
11
0.2
32
0.5
20
0.3
Iowa
11
0.4
8
0.3
7
0.2
17
0.6
12
0.4
Kansas
14
0.5
4
0.1
15
0.5
11
0.4
7
0.2
Kentucky
26
0.6
10
0.2
25
0.6
24
0.5
19
0.4
Louisiana
11
0.2
5
0.1
7
0.2
14
0.3
5
0.1
Maine
7
0.5
6
0.5
9
0.7
10
0.8
8
0.6
Maryland
23
0.4
26
0.4
28
0.5
29
0.5
27
0.5
Massachusetts
48
0.7
39
0.6
40
0.6
43
0.6
43
0.6
Michigan
73
0.7
70
0.7
100
1.0
83
0.8
45
0.5
Minnesota
37
0.7
27
0.5
29
0.5
32
0.6
19
0.3
Mississippi
2
0.1
7
0.2
11
0.4
5
0.2
3
0.1
Missouri
21
0.4
13
0.2
20
0.3
8
0.1
20
0.3
Montana
4
0.4
3
0.3
6
0.6
6
0.6
5
0.5
Nebraska
14
0.8
5
0.3
16
0.9
13
0.7
9
0.5
Nevada
14
0.5
5
0.2
10
0.4
19
0.7
5
0.2
New Hampshire
2
0.2
0
0
6
0.5
9
0.7
5
0.4
New Jersey
76
0.9
79
0.9
60
0.7
68
0.8
59
0.7
New Mexico
5
0.2
7
0.3
10
0.5
20
1.0
8
0.4
New York
147
0.8
113
0.6
111
0.6
167
0.8
84
0.4
North Carolina
48
0.5
31
0.3
34
0.3
46
0.5
38
0.4
North Dakota
4
0.6
0
0
2
0.3
9
1.2
9
1.2
Ohio
47
0.4
39
0.3
36
0.3
59
0.5
32
0.3
Oklahoma
6
0.2
11
0.3
12
0.3
14
0.4
17
0.4
Oregon
17
0.4
11
0.3
9
0.2
29
0.7
13
0.3
Pennsylvania
53
0.4
60
0.5
62
0.5
53
0.4
48
0.4
Rhode Island
9
0.9
8
0.8
3
0.3
4
0.4
8
0.8
South Carolina
26
0.6
11
0.2
6
0.1
14
0.3
6
0.1
South Dakota
1
0.1
2
0.2
0
0
4
0.5
3
0.4
Tennessee
12
0.2
23
0.4
23
0.4
20
0.3
12
0.2
Texas
139
0.6
138
0.5
134
0.5
109
0.4
124
0.5
Utah
12
0.4
8
0.3
4
0.1
12
0.4
8
0.3
Vermont
0
0
6
1.0
2
0.3
7
1.1
1
0.2
Virginia
52
0.6
30
0.4
49
0.6
36
0.4
27
0.3
Washington
21
0.3
31
0.5
29
0.4
45
0.6
26
0.4
West Virginia
15
0.8
8
0.4
8
0.4
4
0.2
12
0.6
Wisconsin
23
0.4
8
0.1
21
0.4
37
0.6
7
0.1
Wyoming
4
0.7
2
0.4
1
0.2
0
0
1
0.2
U.S.
1670
0.5
1398
0.4
1562
0.5
1781
0.6
1239
0.4

*Rate per 100,000 population.
U=No data available for reporting.
Source: CDC, National Notifiable Diseases Surveillance System.

Table 2.2 Clinical characteristics of reported cases of hepatitis A* ― United States, 2014

Clinical characteristic
Availability of valid data† for clinical characteristic
Cases with clinical characteristic§
No.
%
No.
%
Jaundice
757
61.1
456
60.2
Hospitalized for hepatitis A
757
61.1
344
45.4
Died from hepatitis A
671
54.2
0
0

*A total of 1,239 hepatitis A cases were reported during 2014.
†Case-reports for which questions regarding clinical characteristics were answered with “yes” or “no.” Reports with any other response were excluded.
§Numbers and percentages represent only those case-reports for which data regarding clinical characteristics were available; numbers likely are underestimates.
Source: CDC, National Notifiable Diseases Surveillance System.

Table 2.3 Number and rate* of hepatitis A-related deaths, by demographic characteristics and year — United States, 2010–2014

Demographic characteristic
2010
2011
2012
2013
2014
No. Rate No. Rate No. Rate No. Rate No. Rate
  Age Group
(years)
0–34  3 0.00 0 0.00 2 0.00 2 0.00 0 0.00
35–44 7 0.02 1 0.00 5 0.01 2 0.00 4 0.01
45–54 25 0.06 11 0.02 12 0.03 13 0.03 7 0.02
55–64 34 0.09 16 0.04 23 0.06 30 0.08 28 0.07
65–74 10 0.05 12 0.05 17 0.07 19 0.08 19 0.07
≥75 16 0.09 29 0.15 18 0.09 14 0.07 18 0.09
 
Race/
ethnicity
White NH (non-Hispanic) 65 0.03 44 0.02 51 0.02 63 0.02 51 0.02
Black NH 15 0.04 10 0.03 8 0.02 6 0.01 11 0.03
Hispanic 12 0.03 6 0.02 8 0.02 8 0.02 10 0.02
Asian/Pacific Islander 2 0.02 8 0.06 7 0.05 3 0.02 2 0.01
American Indian/Alaska Native 1 0.05 1 0.04 2 0.08 0 0.00 2 0.10
 
Sex Male 73 0.05 37 0.02 46 0.03 50 0.03 42 0.02
Female 22 0.01 32 0.02 31 0.02 30 0.01 34 0.02
 
Overall  95 0.03 69 0.02 77 0.02 80 0.02 76 0.02

Source: CDC, National Vital Statistics System.
*Rates for race, sex, and overall total are age-adjusted per 100,000 U.S. standard population in 2000. Cause of death is defined as the underlying cause of death or one of the multiple causes of death and is based on the International Classification of Diseases, 10th Revision (ICD-10) codes B15 (hepatitis A).
† The race category “white” Included white, non-Hispanic and white Hispanic. The race category “black” included black, non-Hispanic and black Hispanic. The race category “non-white, non-black” included all other races. 
One death in 2012 is not represented under the race/ethnicity category due to missing race and/or ethnicity data.

Figure 2.1. Reported number of hepatitis A cases – United States, 2000-2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 2.2. Incidence of hepatitis A, by age group – United States, 2000-2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 2.3. Incidence of hepatitis A, by sex — United States, 2000–2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 2.4. Incidence of hepatitis A, by race/ethnicity — United States, 2000–2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 2.5. Availability of information on risk exposures/behaviors associated with hepatitis A — United States, 2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 2.6a. Hepatitis A reports, by risk exposure/behavior – United States, 2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 2.6b. Hepatitis A reports, by risk exposure/behavior – United States, 2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

All seven figure slides in PowerPoint ppt icon[PPTX – 820 KB]

Hepatitis B virus

Index
PAGE
DESCRIPTION
Table 3.1 Reported cases of acute hepatitis B, nationally and by state or jurisdiction ― United States, 2010-2014
Table 3.2 Clinical characteristics of reported cases of acute hepatitis B ― United States, 2014
Table 3.3 Number of newly reported case-reports of confirmed chronic hepatitis B submitted by states and jurisdictions, 2014
Table 3.4 Reported cases of chronic hepatitis B, by demographic characteristics and laboratory tests – Enhanced Viral Hepatitis Surveillance Sites, 2014
Table 3.5 Number and rate of hepatitis B-related deaths, by demographic characteristics and year – United States, 2010-2014
Figure 3.1 Reported number of acute hepatitis B cases — United States, 2000-2014
Figure 3.2 Incidence of acute hepatitis B, by age group — United States, 2000-2014
Figure 3.3 Incidence of acute hepatitis B, by sex — United States, 2000-2014
Figure 3.4 Incidence of acute hepatitis B, by race/ethnicity — United States, 2000-2014
Figure 3.5 Availability of information on risk behaviors/exposures associated with acute hepatitis B — United States, 2014
Figure 3.6a Acute hepatitis B reports, by risk behavior — United States, 2014
Figure 3.6b Acute hepatitis B reports, by risk exposure — United States, 2014

Hepatitis B virus

Table 3.1 Reported cases of acute hepatitis B, nationally and by state or jurisdiction ― United States, 2010-2014

State
2010
2011
2012
2013
2014
No. Rate* No. Rate* No. Rate* No. Rate* No. Rate*
Alabama 68 1.4 119 2.5 79 1.6 90 1.9 117 2.4
Alaska 5 0.7 3 0.4 1 0.1 1 0.1 3 0.4
Arizona 26 0.4 14 0.2 14 0.2 28 0.4 31 0.5
Arkansas 66 2.3 57 1.9 74 2.5 50 1.7 28 0.9
California 252 0.7 157 0.4 136 0.4 138 0.4 110 0.3
Colorado 46 0.9 23 0.4 24 0.5 24 0.5 29 0.5
Connecticut 22 0.6 19 0.5 15 0.4 8 0.2 9 0.3
Delaware U U 13 1.4 11 1.2 14 1.5 8 0.9
District of Columbia 3 0.5 U U U U U U U U
Florida 297 1.6 213 1.1 247 1.3 323 1.7 313 1.6
Georgia 165 1.7 142 1.4 109 1.1 104 1.0 103 1.0
Hawaii 6 0.4 6 0.4 5 0.4 4 0.3 6 0.4
Idaho 6 0.4 2 0.1 5 0.3 13 0.8 6 0.4
Illinois 135 1.1 85 0.7 86 0.7 94 0.7 58 0.5
Indiana 75 1.2 70 1.1 90 1.4 101 1.5 126 1.9
Iowa 15 0.5 15 0.5 13 0.4 11 0.4 9 0.3
Kansas 11 0.4 15 0.5 9 0.3 11 0.4 11 0.4
Kentucky 136 3.1 151 3.5 180 4.1 214 4.9 164 3.7
Louisiana 55 1.2 62 1.4 44 1.0 82 1.8 87 1.9
Maine 13 1.0 8 0.6 9 0.7 11 0.8 12 0.9
Maryland 67 1.2 62 1.1 52 0.9 43 0.7 40 0.7
Massachusetts 13 0.2 67 1.0 75 1.1 71 1.1 30 0.4
Michigan 122 1.2 91 0.9 81 0.8 53 0.5 50 0.5
Minnesota 23 0.4 20 0.4 17 0.3 19 0.4 16 0.3
Mississippi 33 1.1 57 1.9 78 2.6 55 1.8 48 1.6
Missouri 67 1.1 60 1.0 48 0.8 61 1.0 31 0.5
Montana 0 0.0 0 0.0 2 0.2 4 0.4 0 0.0
Nebraska 12 0.7 12 0.7 10 0.5 9 0.5 8 0.4
Nevada 41 1.5 29 1.1 28 1.0 29 1.0 21 0.7
New Hampshire 5 0.4 3 0.2 4 0.3 2 0.2 4 0.3
New Jersey 77 0.9 73 0.8 70 0.8 65 0.7 77 0.9
New Mexico 5 0.2 10 0.5 3 0.1 3 0.1 2 0.1
New York 139 0.7 134 0.7 113 0.6 117 0.6 95 0.5
North Carolina 113 1.2 109 1.1 73 0.7 75 0.8 100 1.0
North Dakota 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Ohio 95 0.8 90 0.8 178 1.5 225 1.9 171 1.5
Oklahoma 115 3.1 100 2.6 79 2.1 40 1.0 57 1.5
Oregon 42 1.1 32 0.8 25 0.6 32 0.8 32 0.8
Pennsylvania 72 0.6 84 0.7 63 0.5 43 0.3 68 0.5
Rhode Island U U U U U U U U U U
South Carolina 59 1.3 39 0.8 37 0.8 58 1.2 37 0.8
South Dakota 2 0.2 2 0.2 2 0.2 5 0.6 3 0.4
Tennessee 150 2.4 192 3.0 240 3.7 262 4.0 232 3.5
Texas 394 1.6 204 0.8 170 0.7 142 0.5 122 0.5
Utah 8 0.3 10 0.4 13 0.5 5 0.2 11 0.4
Vermont 2 0.3 0 0.0 2 0.3 2 0.3 4 0.6
Virginia 97 1.2 84 1.0 84 1.0 72 0.9 61 0.7
Washington 50 0.7 35 0.5 34 0.5 33 0.5 44 0.6
West Virginia 88 4.7 113 6.1 141 7.6 195 10.5 186 10.1
Wisconsin 54 0.9 17 0.3 22 0.4 9 0.2 11 0.2
Wyoming 3 0.5 0 0.0 0 0.0 U U U U
Total 3350 1.1 2903 0.9 2895 0.9 3050 1.0 2791 0.9

Source: CDC, National Notifiable Diseases Surveillance System.
*Rate per 100,000 population.
Updated data for Delaware in 2011.
U=No data available for reporting.

Table 3.2 Clinical characteristics of reported cases of acute hepatitis B* ― United States, 2014

Clinical characteristic
Availability of valid data† for clinical characteristic
Cases with clinical characteristic§
No.
%
No.
%
Jaundice
2,021 72.4 1,544 76.4
Hospitalized for hepatitis B
2,014 72.2 1,240 61.6
Died from hepatitis B
1,806 64.7 13 0.7

Source: CDC, National Notifiable Diseases Surveillance System.
*A total of 2,791 hepatitis B cases were reported during 2014.
Case-reports for which questions regarding clinical characteristics were answered with “yes” or “no.” Reports with any other response were excluded.
§Numbers and percentages represent only those case-reports for which data regarding clinical characteristics were available; numbers likely are underestimates.

Table 3.3 Number of newly reported case-reports* of confirmed chronic hepatitis B submitted by states and jurisdictions, 2014

State/Jurisdiction No. chronic hepatitis B
case reports submitted
Alabama N§
Alaska N
Arizona 98
Arkansas N
California 1,114
Colorado 144
Connecticut 72
Delaware 88
District of Columbia U
Florida 1,137
Georgia N
Hawaii 182
Idaho 51
Illinois 972
Indiana U
Iowa 66
Kansas 116
Kentucky N
Louisiana 125
Maine 44
Maryland 498
Massachusetts 233
Michigan 475
Minnesota 197
Mississippi N
Missouri 431
Montana 26
Nebraska 110
Nevada N
New Hampshire 28
New Jersey 487
New Mexico 50
New York State 2,255
North Carolina 447
North Dakota 83
Ohio 214
Oklahoma 86
Oregon 97
Pennsylvania 927
Rhode Island U
South Carolina 145
South Dakota 10
Tennessee 625
Texas N
Utah 34
Vermont 34
Virginia 341
Washington 93
West Virginia 218
Wisconsin 1
Wyoming 46
Total 12,400

Source: CDC, National Notifiable Diseases Surveillance System.
*For case-definition, see https://wwwn.cdc.gov/nndss/conditions/notifiable/2016/
Reports may not reflect unique cases.
§ N= Not Reportable, past/present hepatitis C infection is not reportable in the listed state. 
Cases reported by California through NNDSS were all from San Francisco County.  Differences in the number o cases in this table and table 3.4 is because NNSDSS and CDC’s Secure Access Management System (SAMS) have different deadline dated for which all annual data must be submitted.
**U=No data available for reporting

Table 3.4. Reported cases of chronic hepatitis B, by demographic characteristics and laboratory tests – Enhanced Viral Hepatitis Surveillance Sites*, 2014

Category MA
No. %
MI
No. %
NYS†
No. %
Phil
No. %
SF
No. %
WA
No. %
Total
No. %
Sex
Female 110 240 253 32 588 28 1,251
49.1% 49.5% 42.7% 34.4% 50.5% 31.1% 47.2%
Male 114 245 337 60 575 62 1,393
50.9% 50.5% 56.8% 64.5% 49.4% 68.9% 52.6%
Unknown/
missing
0 0 3 1 2 0 6
0.0% 0.0% 0.5% 1.1% 0.2% 0.0% 0.2%
Race/ethnicity
American Indian/
Alaskan Native,
non- Hispanic (NH)
0 3 0 0 4 0 7
0.0% 0.6% 0.0% 0.0% 0.3% 0.0% 0.3%
Asian / Pacific
Islander,  NH
66 139 209 35 603 22 1,074
29.5% 28.7% 35.2% 37.6% 51.8% 24.4% 40.5%
Black,  NH 35 75 81 25 20 6 242
15.60% 15.50% 13.70% 26.90% 1.70% 6.70% 9.10%
White,  NH 28 149 96 5 20 11 309
12.5% 30.7% 16.2% 5.4% 1.7% 12.2% 11.7%
Hispanic 24 9 24 2 19 1 79
10.7% 1.9% 4.1% 2.2% 1.6% 1.1% 3.0%
Other,  NH 16 25 21 2 7 2 73
7.1% 5.2% 3.5% 2.2% 0.6% 2.2% 2.8%
Unknown/
missing
55 85 162 24 492 48 866
24.6% 17.5% 27.3% 25.8% 42.2% 53.3% 32.7%
Age group, years
0-14 1 8 4 3 5 0 21
0.4% 1.6% 0.7% 3.2% 0.4% 0.0% 0.8%
15-24 13 49 38 8 35 9 152
5.8% 10.1% 6.4% 8.6% 3.0% 10.0% 5.7%
25-39 94 149 205 31 373 29 881
42.0% 30.7% 34.6% 33.3% 32.0% 32.2% 33.2%
40-54 68 143 195 33 422 31 892
30.4% 29.5% 32.9% 35.5% 36.2% 34.4% 33.7%
55+ 48 136 151 18 329 21 703
21.4% 28.0% 25.5% 19.4% 28.2% 23.3% 26.5%
Unknown/
missing
0 0 0 0 1 0 1
0.0% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0%
Place of birth
United States 19 114 3 42 12 1 191
8.5% 23.5% 0.5% 45.2% 1.0% 1.1% 7.2%
Outside United States 103 168 10 44 113 36 474
46.0% 34.6% 1.7% 47.3% 9.7% 40.0% 17.9%
Unknown/
missing
102 203 580 7 1040 53 1,985
45.5% 41.9% 97.8% 7.5% 89.3% 58.9% 74.9%
Hepatitis B laboratory testing¶
HBV surface antigen + 190 326 524 65 1053 21 2,179
84.8% 67.2% 88.4% 69.9% 90.4% 23.3% 82.2%
[IgM anti-HBc] – 71 80 111 0 0 44 306
31.7% 16.5% 18.7% 0.0% 0.0% 48.9% 11.5%
HBV “e” antigen + 70 30 97 15 71 4 287
31.3% 6.2% 16.4% 16.1% 6.1% 4.4% 10.8%
HBV NAT + 155 50 268 86 999 17 1,577
69.2% 10.3% 45.2% 92.5% 85.8% 18.9% 59.4%
Total no. cases  224 485 593 93 1,165 90 2,650
2013 Estimated
population total**
6,745,408 9,909,877 11,255,148 1,560,297 852,469 7,061,530 37,384,729
Rate per 100,000
population
3.3 4.9 5.3 6 136.7 1.3 7.1

Source: CDC, Enhanced Viral Hepatitis Surveillance Sites.
Abbreviations: MA, Massachusetts; MI, Michigan; NYS, New York State; Phil, Philadelphia; SF, San Francisco; WA, Washington State
*Chronic hepatitis B data from Florida, one of the 7 funded sites, were not included in this table.
New York City was not included in the case count for New York State, therefore cases and population estimates from New York excluded those who resided in New York City
§The denominator used to calculate proportions was the total number of cases reported for each site.
Cases can be reported with more than one laboratory test result.
**Population estimates for the United States: https://wonder.cdc.gov/bridged-race-population.html.

Table 3.5. Number and rate* of hepatitis B-related deaths, by demographic characteristics and year – United States, 2010-2014

Demographic
characteristic
2010
2011
2012
2013
2014
No. Rate No. Rate No. Rate No. Rate No. Rate
  Age Group
(years)
0–34  48 0.03 41 0.03 38 0.03 40 0.03 35 0.02
35–44 142 0.35 143 0.35 123 0.30 146 0.36 126 0.31
45–54 448 1.00 421 0.94 428 0.97 389 0.89 384 0.88
55–64 610 1.67 645 1.69 639 1.66 704 1.79 684 1.71
65–74 296 1.36 285 1.27 314 1.31 343 1.36 358 1.36
≥75 248 1.34 269 1.42 229 1.20 251 1.29 256 1.29
 
Race / ethnicity White NH (non-Hispanic) 856 0.34 832 0.32 818 0.31 868 0.33 853 0.32
Black NH 356 0.94 373 0.98 322 0.81 384 0.98 330 0.80
Hispanic 136 0.43 161 0.48 139 0.39 149 0.39 155 0.38
Asian / Pacific Islander 421 2.95 422 2.72 469 2.93 451 2.64 478 2.71
American Indian / Alaska Native 17 0.73 9 0.39 18 0.74 14 0.55 11 0.43
 
Sex Male 1,316 0.81 1,321 0.80 1,272 0.75 1,375 0.79 1,307 0.74
Female 476 0.27 483 0.26 499 0.27 498 0.26 536 0.27
 
Overall  1,792 0.52 1,804 0.52 1,771 0.50 1,873 0.52 1,843 0.50

*Rates for race, sex, and overall total are age-adjusted per 100,000 U.S. standard population in 2000.
†Cause of death is defined as the underlying cause of death or one of the multiple causes of death and is based on the International Classification of Diseases, 10th Revision (ICD-10) codes B16, B17.0, B18.0, B18.1 (hepatitis B).
§ Six deaths in 2010, seven deaths in 2011, five deaths in 2012, seven deaths in 2013, and 16 deaths in 2014 are not represented under the race/ethnicity category due to missing race and/or ethnicity data.
Source: CDC, National Vital Statistics System.

Figure 3.1. Reported number of acute hepatitis B cases — United States, 2000–2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 3.2. Incidence of acute hepatitis B, by age group — United States, 2000–2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 3.3. Incidence of acute hepatitis B, by sex — United States, 2000–2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 3.4. Incidence of acute hepatitis B, by race/ethnicity — United States, 2000–2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 3.5. Availability of information on risk exposures/behaviors associated with acute hepatitis B — United States, 2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 3.6a. Acute hepatitis B reports, by risk exposure/behavior — United States, 2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 3.6b. Acute hepatitis B reports, by risk exposure/behavior — United States, 2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

All seven figure slides in PowerPoint ppt icon[PPTX – 371 KB]

Hepatitis C virus

Index
PAGE
DESCRIPTION
Table 4.1 Reported cases of acute hepatitis C, nationally and by state and jurisdiction ― United States, 2010-2014
Table 4.2 Clinical characteristics of reported cases of acute hepatitis C ― United States, 2014
Table 4.3 Number of newly reported case-reports of confirmed past or present hepatitis C infection submitted by states, 2014
Table 4.4 Reported cases of past or present hepatitis C, by demographic characteristics and laboratory tests – Enhanced Viral Hepatitis Surveillance Sites, 2014
Table 4.5 Number and rate of hepatitis C-related deaths, by demographic characteristics and year – United States, 2010-2014
Slide 4.1 Reported number of acute hepatitis hepatitis C cases — United States, 2000-2014
Slide 4.2 Incidence of acute hepatitis C, by age group — United States, 2000-2014
Slide 4.3 Incidence of acute hepatitis C, by sex — United States, 2000-2014
Slide 4.4 Incidence of acute hepatitis C, by race/ethnicity — United States, 2000-2014
Slide 4.5 Availability of information on risk exposures/behaviors associated with acute hepatitis C — United States, 2014
Slide 4.6a Acute hepatitis C reports, by risk behavior — United States, 2014
Slide 4.6b Acute hepatitis C reports, by risk exposure — United States, 2014

Hepatitis C virus

Table 4.1 Reported cases of acute hepatitis C, nationally and by state state and jurisdiction ― United States, 2010-2014

State
2010
2011
2012
2013
2014
No. Rate* No. Rate* No. Rate* No. Rate* No. Rate*

Alabama

7 0.1 23 0.5 24 0.5 30 0.6 35 0.7

Alaska

U U U U U U U U U U

Arizona

U U U U U U U U U U

Arkansas

1 0 0 0 5 0.2 30 1.0 13 0.4

California

32 0.1 48 0.1 63 0.2 72 0.2 73 0.2

Colorado

20 0.4 28 0.5 42 0.8 21 0.4 33 0.6

Connecticut

37 1.0 47 1.3 34 0.9 U U U U

Delaware

U U 3 0.3 U U U U U U

District of Columbia

2 0.3 U U U U U U U U

Florida

56 0.3 64 0.3 107 0.6 134 0.7 93 0.5

Georgia

32 0.3 53 0.5 82 0.8 48 0.5 57 0.6

Hawaii

U U U U U U U U U U

Idaho

11 0.7 12 0.8 11 0.7 14 0.9 6 0.4

Illinois

1 0 6 0 26 0.2 37 0.3 27 0.2

Indiana

27 0.4 84 1.3 110 1.7 175 2.7 122 1.8

Iowa

0 0 0 0 3 0.1 U U U U

Kansas

2 0.1 8 0.3 16 0.6 17 0.6 28 1.0

Kentucky

109 2.5 142 3.2 178 4.1 226 5.1 176 4.0

Louisiana

4 0.1 7 0.2 11 0.2 19 0.4 22 0.5

Maine

2 0.2 12 0.9 8 0.6 8 0.6 31 2.3

Maryland

24 0.4 35 0.6 39 0.7 53 0.9 42 0.7

Massachusetts

13 0.2 23 0.3 37 0.6 174 2.6 228 3.4

Michigan

45 0.5 32 0.3 76 0.8 74 0.7 78 0.8

Minnesota

16 0.3 17 0.3 32 0.6 47 0.9 40 0.7

Mississippi

U U U U U U U U U U

Missouri

6 0.1 8 0.1 4 0.1 6 0.1 6 0.1

Montana

4 0.4 9 0.9 9 0.9 16 1.6 13 1.3

Nebraska

2 0.1 2 0.1 3 0.2 2 0.1 2 0.1

Nevada

7 0.3 10 0.4 12 0.4 9 0.3 6 0.2

New Hampshire

U U U U U U U U U U

New Jersey

28 0.3 53 0.6 71 0.8 106 1.2 113 1.3

New Mexico

14 0.7 14 0.7 21 1.0 12 0.6 16 0.8

New York

50 0.3 52 0.3 93 0.5 131 0.7 126 0.6

North Carolina

39 0.4 60 0.6 63 0.6 79 0.8 111 1.1

North Dakota

0 0 0 0 0 0 4 0.6 0 0

Ohio

10 0.1 6 0.1 7 0.1 116 1.0 105 0.9

Oklahoma

41 1.1 53 1.4 80 2.1 40 1.0 45 1.2

Oregon

19 0.5 20 0.5 37 0.9 14 0.4 15 0.4

Pennsylvania

26 0.2 35 0.3 66 0.5 81 0.6 69 0.5

Rhode Island

U U U U U U U U U U

South Carolina

1 0 1 0 1 0 0 0 4 0.1

South Dakota

U U U U U U 1 0.1 0 0

Tennessee

46 0.7 83 1.3 129 2 98 1.5 123 1.9

Texas

35 0.1 37 0.1 44 0.2 28 0.1 47 0.2

Utah

10 0.4 10 0.4 17 0.6 11 0.4 38 1.3

Vermont

2 0.3 6 1.0 6 1.0 3 0.5 4 0.6

Virginia

13 0.2 25 0.3 76 0.9 41 0.5 54 0.6

Washington

25 0.4 41 0.6 54 0.8 63 0.9 82 1.2

West Virginia

21 1.1 46 2.5 55 3.0 58 3.1 62 3.4

Wisconsin

10 0.2 15 0.3 26 0.5 40 0.7 49 0.9

Wyoming

0 0 2 0.4 U U U U U U

Total

850 0.3 1232 0.4 1778 0.6 2138 0.7 2194 0.7

Source: CDC, National Notifiable Diseases Surveillance System.
*Rate per 100,000 population.
U=No data available for reporting.

Table 4.2 Clinical characteristics of reported cases of acute hepatitis C* ― United States, 2014

Clinical characteristic
Availability of valid data† for clinical characteristic
Cases with clinical characteristic§
No.
%
No.
%
Jaundice
1,527 69.6 917 60.1
Hospitalized for hepatitis C
1,371 62.5 733 53.5
Died from hepatitis C
1,242 56.6 6 0.5

Source: CDC, National Notifiable Diseases Surveillance System.
*A total of 2,194 acute hepatitis C cases were reported during 2014.
Case-reports for which questions regarding clinical characteristics were answered with “yes” or “no.” Reports with any other response were excluded.
§Numbers and percentages represent only those case-reports for which data regarding clinical characteristics were available; numbers likely are underestimates.

Table 4.3 Number of newly reported case-reports* of confirmed past or present hepatitis C infection submitted by states, 2014

State/Jurisdiction No. past/present hepatitis
 case-reports submitted
Alabama N§
Alaska U
Arizona U
Arkansas N
California** 1,317
Colorado 3,644
Connecticut 3,263
Delaware U
District of Columbia U
Florida 22,253
Georgia 4,237
Hawaii 11
Idaho 932
Illinois 8,777
Indiana U
Iowa U
Kansas 1,560
Kentucky N
Louisiana 2,116
Maine 1,423
Maryland 7,041
Massachusetts 5,639
Michigan 7,572
Minnesota 1,899
Mississippi N
Missouri 6,278
Montana 1,413
Nebraska 926
Nevada N
New Hampshire N
New Jersey 7,765
New Mexico 2,316
New York State 15,787
North Carolina N
North Dakota 848
Ohio 15,755
Oklahoma 541
Oregon 5,002
Pennsylvania 10,395
Rhode Island U
South Carolina 3,586
South Dakota 522
Tennessee N
Texas N
Utah 1,492
Vermont 902
Virginia 5,590
Washington 4,928
West Virginia 6,631
Wisconsin U
Wyoming 502
Total 162,863

Source: CDC, National Notifiable Diseases Surveillance System
*For case-definition, see http://wwwn.cdc.gov/nndss/script/ConditionList.aspx?Type=0&Yr=2012.
Reports may not reflect unique cases.
§N=Not Reportable, past/present hepatitis C is not reportable in the listed state.
U= No data available for reporting
** Cases reported by California through NNDSS were all from San Francisco County.  Differences in the number o cases in this table and table 3.4 is because NNSDSS and CDC’s Secure Access Management System (SAMS) have different deadline dated for which all annual data must be submitted.

Table 4.4. Reported cases of past or present hepatitis C, by demographic characteristics and laboratory tests – Enhanced Viral Hepatitis Surveillance Sites, 2014

Category FL
No. %
MA
No. %
MI
No. %
NYS†
No. %
Phil
No. %
SF
No. %
WA
No. %
Total
No. %
Sex
Female 572 2,031 2,748 3,008 488 503 1,945 11,295
54.1% 38.6% 36.5% 40.9% 35.5% 30.1% 39.9% 38.8%
Male 484 3,212 4,769 4,293 849 1158 2,878 17,643
45.8% 61.0% 63.3% 58.3% 61.7% 69.2% 59.0% 60.5%
Unknown/
missing
1 20 16 58 39 12 55 201
0.1% 0.4% 0.2% 0.8% 2.8% 0.7% 1.1% 0.7%
Race/ethnicity
American Indian/
Alaskan Native,
non-Hispanic (NH)
2 10 62 32 1 9 0 116
0.2% 0.2% 0.8% 0.4% 0.1% 0.5% 0.0% 0.4%
Asian/Pacific
Islander,  NH
6 67 48 92 13 67 49 342
0.6% 1.3% 0.6% 1.3% 0.9% 4.0% 1.0% 1.2%
Black,  NH 65 171 1,457 735 217 274 115 3,034
6.1% 3.2% 19.3% 10.0% 15.8% 16.4% 2.4% 10.4%
White,  NH 705 1,953 3,875 3,443 196 549 1,102 11,823
66.7% 37.1% 51.4% 46.8% 14.2% 32.8% 22.6% 40.6%
Hispanic 84 254 149 401 76 134 70 1,168
7.9% 4.8% 2.0% 5.4% 5.5% 8.0% 1.4% 4.0%
Other,  NH 6 127 103 111 11 21 43 422
0.6% 2.4% 1.4% 1.5% 0.8% 1.3% 0.9% 1.4%
Unknown/
missing
189 2,681 1,839 2,545 862 619 3,499 12,234
17.9% 50.9% 24.4% 34.6% 62.6% 37.0% 71.7% 42.0%
Age group, years
0-14 5 45 26 16 5 0 15 112
0.5% 0.9% 0.3% 0.2% 0.4% 0.0% 0.3% 0.4%
15-24 246 679 587 776 40 44 367 2,739
23.3% 12.9% 7.8% 10.5% 2.9% 2.6% 7.5% 9.4%
25-39 450 1,874 1,728 1,824 224 286 981 7,367
42.6% 35.6% 22.9% 24.8% 16.3% 17.1% 20.1% 25.3%
40-54 157 1,295 1,797 1,756 416 493 1,591 7,505
14.9% 24.6% 23.9% 23.9% 30.2% 29.5% 32.6% 25.8%
55+ 199 1,370 3,395 2,969 691 832 1,924 11,380
18.8% 26.0% 45.1% 40.3% 50.2% 49.7% 39.4% 39.1%
Unknown/
missing
0 0.00% 0 18 0 18 0 36
0.0% 0.0% 0.0% 0.2% 0.0% 1.1% 0.0% 0.1%
Hepatitis C laboratory testing§
Anti-HCV+ 761 3,050 5,308 5,014 644 986 1,271 17,034
72.0% 58.0% 70.5% 68.1% 46.8% 58.9% 26.1% 58.4%
HCV

RNA +

535 3,206 2,310 4,865 1,334 1,128 2,952 16,330
50.6% 60.9% 30.7% 66.1% 96.9% 67.4% 60.5% 56.0%
Total no. cases  1,057 5,263 7,533 7,359 1,376 1,673 4,878 29,139
2013 Estimated
population total**
19,893,297 6,745,408 9,909,877 11,255,148 1,560,297 852,469 5,470,019 55,686,515
Rate per 100,000
population
5.3 78.0 76.0 65.4 88.2 196.3 89.2 52.3

Source: CDC, Enhanced Viral Hepatitis Surveillance Sites.
Abbreviations: MA, Massachusetts; MI, Michigan; NYS, New York State; Phil, Philadelphia; SF, San Francisco; WA, Washington State
*Cases and population estimates from New York excluded those who resided in New York City because New York City was not included in the reported case counts.
†The denominator used to calculate proportions was the total number of cases reported for each site.
§Cases can be reported with more than one laboratory test result.
¶Population estimates for the United States: https://wonder.cdc.gov/bridged-race-population.html.

Table 4.5. Number and rate* of hepatitis C-related deaths, by demographic characteristics and year – United States, 2010-2014

Demographic characteristic
2010
2011
2012
2013
2014
No. Rate No. Rate No. Rate No. Rate No. Rate
  Age Group
(years)
0–34  117 0.08 128 0.09 158 0.11 121 0.08 162 0.11
35–44 712 1.73 696 1.71 622 1.54 573 1.42 552 1.36
45–54 5,171 11.49 5,073 11.34 4,749 10.73 4,344 9.93 4,118 9.48
55–64 7,431 20.37 8,330 21.89 9,235 23.93 9,899 25.18 9,999 24.95
65–74 1,901 8.75 2,136 9.50 2,515 10.49 3,004 11.91 1,433 7.22
≥75 1,293 6.97 1,357 7.18 1,369 7.15 1,425 7.31 1,433 7.22
 
Race / ethnicity White NH (non-Hispanic) 10,575 4.03 11,196 4.19 11,839 4.35 12,219 4.40 12,455 4.46
Black NH 2,981 7.72 3,167 7.89 3,232 7.81 3,520 8.35 3,540 8.12
Hispanic 2,318 6.83 2,555 7.15 2,668 7.19 2,699 6.91 2,767 6.81
Asian/Pacific Islander 440 3.30 455 3.14 472 3.15 495 3.09 438 2.56
American Indian/Alaska Native 248 9.90 275 10.61 313 11.81 324 12.22 317 11.20
 
Sex Male 11,718 6.81 12,651 7.11 13,300 7.31 13,745 7.40 13,998 7.39
Female 4,846 2.63 5,080 2.70 5,350 2.77 5,623 2.85 5,661 2.81
 
Overall  16,627 4.56 17,721 4.82 18,650 4.96 19,368 5.03 19,659 5.01

Source: CDC, National Vital Statistics System.
*Rates for race, sex, and overall total are age-adjusted per 100,000 U.S. standard population in 2000.
Cause of death is defined as the underlying cause of death or one of the multiple causes of death and is based on the International Classification of Diseases, 10th Revision (ICD-10) codes B17.1, and B18.2 (hepatitis C).
§Two deaths in 2010, one death in 2011, two deaths in 2012, two deaths in 2013, and five deaths in 2014 are not represented under the age category due to missing age data.
The race/ethnicity category was added starting in 2010 to incorporate bridged race categories. 65 deaths in 2010, 73 deaths in 2011, 126 deaths in 2012, 111 deaths in 2013, and 142 deaths in 2014 are not represented under the race/ethnicity category due to missing race and/or ethnicity data.

Figure 4.1. Reported number of acute hepatitis C cases — United States, 2000–2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 4.2. Incidence of acute hepatitis C, by age group — United States, 2000–2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 4.3. Incidence of acute hepatitis C, by sex — United States, 2000–2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 4.4. Incidence of acute hepatitis C, by race/ethnicity — United States, 2000–2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 4.5. Availability of information on risk exposures/behaviors associated with acute hepatitis C — United States, 2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 4.6a. Acute hepatitis C reports, by risk exposure/behavior — United States, 2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 4.6b. Acute hepatitis C reports, by risk exposure/behavior — United States, 2014
Downloads of this slide: PDFpdf icon    PowerPointppt icon

All seven figure slides in PowerPoint ppt icon[PPTX – 369 KB]

* Originally posted 5/4/16, corrected version posted 5/16/16